Antipsychotic Agents: all 1,683 studies that test it
Page 14 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- Health Evaluation of Abilify Long-term TherapyCompletedNCT00520650Phase 4
- An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed PatientsCompletedNCT00520507Phase 4
- The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar DepressionCompletedNCT00517387Phase 3
- Subcutaneous Olanzapine for Hyperactive or Mixed DeliriumCompletedNCT00512291Not applicable
- Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot StudyCompletedNCT00511277Phase 4
- Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective DisorderCompletedNCT00501618Phase 4
- Quality of Life (QOL) in Female Patient With SchizophreniaTerminatedNCT00498004Phase 4
- A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.CompletedNCT00495118Phase 3
- Olanzapine in Patients With Advanced Cancer and Weight LossCompletedNCT00489593Phase 1
- FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute PsychosisTerminatedNCT00486798Phase 3
- Weight Gain Management in Patients With SchizophreniaCompletedNCT00486005Phase 4
- Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With SchizophreniaCompletedNCT00485901Phase 3
- Assessment of a Weight Management Program for Weight Gain in Patients With SchizophreniaCompletedNCT00485823Phase 4
- Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With SchizophreniaCompletedNCT00485810Phase 1/2
- Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I DepressionCompletedNCT00485771Phase 4
- Olanzapine Versus Comparator in the Treatment of Bipolar DisorderCompletedNCT00485680Phase 3
- Managing Acute Schizophrenia, a Comparison Between Two Atypical AntipsychoticsCompletedNCT00485498Phase 4
- ABLE: Abilify in Bipolar Disorder for Long-term EffectivenessCompletedNCT00484471Phase 4
- Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus RisperidoneStatus unknownNCT00480844Phase 4
- A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET TracerCompletedNCT00480246Phase 1
- Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive BehaviorsCompletedNCT00471588Phase 1
- The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole TrialStatus unknownNCT00468533Phase 4
- Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous TreatmentCompletedNCT00466609Phase 4
- Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective DisordersCompletedNCT00462618Phase 2/3
- An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With SchizophreniaCompletedNCT00460512Phase 3
- Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective DisorderTerminatedNCT00457899Phase 3
- A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic AttacksCompletedNCT00457106Not applicable
- Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode PsychosisCompletedNCT00449397Phase 3
- Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder PatientsCompletedNCT00448578Phase 3
- Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative NauseaTerminatedNCT00445055Phase 4
- Zyprexa and Task Engagement in SchizophreniaWithdrawnNCT00440843Phase 3
- Aripiprazole in the Treatment of Post-Traumatic Stress Disorder SymptomsCompletedNCT00440713Phase 3
- Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological GamblingCompletedNCT00438776Phase 3
- Aripiprazole for the Treatment of Refractory AnxietyCompletedNCT00438386Phase 4
- Amisulpride in Schizophrenic Acute Phase PatientsCompletedNCT00436371Phase 4
- Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSDCompletedNCT00433121Phase 4
- Pilot Study of Haloperidol to Treat Critical Illness DeliriumCompletedNCT00429676Phase 2
- Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute SchizophrenicCompletedNCT00428350Phase 4
- Phase III/Seroquel SR Bipolar Depression Monotherapy - USCompletedNCT00422214Phase 3
- Phase 3 /Seroquel SR Acute Mania Monotherapy - USCompletedNCT00422123Phase 3
- Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological TherapyTerminatedNCT00419653Phase 4
- Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute WardTerminatedNCT00418873Phase 4
- Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)CompletedNCT00418171Phase 4
- The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking EnvironmentCompletedNCT00407199Phase 4
- Study Evaluating RGH-188 in the Treatment of Patients With SchizophreniaCompletedNCT00404573Phase 2
- Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.CompletedNCT00399698Phase 3
- Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of SchizophreniaStatus unknownNCT00395915Phase 4
- Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective DisorderCompletedNCT00395031Phase 2/3
- Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.CompletedNCT00380224Phase 3
- A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.CompletedNCT00378183Phase 4
- A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic EpisodeCompletedNCT00378092Phase 4
- Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia PatientsWithdrawnNCT00375557Phase 4
- Comparison of Applied Behavioral Analysis (ABA) Versus ABA and RisperidoneCompletedNCT00374764Not applicable
- Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)CompletedNCT00374348Not applicable
- Quetiapine and the Dopaminergic Epigenetic ControlCompletedNCT00370500Phase 4
- Prochlorperazine vs MetoclopramideCompletedNCT00364806Phase 4
- A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar DepressionCompletedNCT00363337Phase 4
- Aripiprazole and Effexor XR Drug Interaction StudyCompletedNCT00362271Phase 1
- Aripiprazole and Lexapro Drug Interaction StudyCompletedNCT00361790Phase 1
- Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and RisperidoneCompletedNCT00361166Phase 2
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCompletedNCT00351910Phase 3
- Switch Study of Existing Atypical Antipsychotics to BifeprunoxCompletedNCT00347425Phase 3
- Augmenting Clozapine With Sertindole - SERCLOZCompletedNCT00345982Not applicable
- A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeWithdrawnNCT00338273Phase 3
- Fluphenazine in Treating Patients With Refractory Advanced Multiple MyelomaCompletedNCT00335647Phase 1/2
- Antipsychotic Therapy and First EpisodeCompletedNCT00334035Phase 4
- Amisulpride in Schizophrenic PatientsCompletedNCT00331981Phase 4
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or ParkinsonismCompletedNCT00331825Phase 4
- Effect on Cognitive Function of a Treatment With AripiprazoleCompletedNCT00329810Phase 4
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety DisorderCompletedNCT00329446Phase 3
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety DisorderCompletedNCT00329264Phase 3
- Seroquel STACK Study in Schizophrenic or Schizoaffective SubjectsCompletedNCT00328978Phase 3
- Quetiapine for Primary Insomnia Patients : A Randomized Controlled TrialCompletedNCT00328822Not applicable
- Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory SchizophreniaCompletedNCT00328367Phase 4
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive DisordersCompletedNCT00326144Phase 3
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive DisordersCompletedNCT00326105Phase 3
- Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.CompletedNCT00325689Phase 4
- Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety DisorderCompletedNCT00322595Phase 3
- Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I DisorderCompletedNCT00321516Phase 1
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive DisorderCompletedNCT00321490Phase 3
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive DisorderCompletedNCT00320268Phase 3
- Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg StudyCompletedNCT00318539Phase 2
- Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.CompletedNCT00314210Phase 3
- Quetiapine Fumarate Bipolar Maintenance MonotherapyCompletedNCT00314184Phase 3
- Risperdal Consta and Health Care Utilization in Patients With SchizophreniaCompletedNCT00313391Phase 4
- A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I DisorderCompletedNCT00309699Phase 3
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I DisorderCompletedNCT00309686Phase 3
- Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and HostilityCompletedNCT00308360Phase 4
- Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress DisorderCompletedNCT00306540Phase 3
- Identification and Treatment of the Liability to Develop SchizophreniaStatus unknownNCT00305474Phase 4
- Effect of Quetiapine on Negative Symptoms and CognitionCompletedNCT00305422Phase 3
- Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHDCompletedNCT00305370Phase 4
- Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)CompletedNCT00304655Phase 4
- SWitching to Abilify Trial (SWAT)CompletedNCT00304616Phase 4
- Fast Titration in the Treatment of Schizophrenia, TaiwanCompletedNCT00304473Phase 3
- Efficacy of Quetiapine in Generalised Social Anxiety DisorderTerminatedNCT00302770Phase 3
- A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic PatientsCompletedNCT00300846Phase 4
- A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I DisorderCompletedNCT00299715Phase 3
- High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective DisorderCompletedNCT00297947Phase 2/3
- Risperidone Augmentation for Treatment-Resistant Aggression in ADHDCompletedNCT00297739Phase 4